Jason Gidelson

Jason Gidelson is an accomplished executive with extensive experience in market access and payer marketing within the pharmaceutical industry. Currently serving as Vice President of U.S. Market Access at Alnylam Pharmaceuticals since October 2023, Gidelson previously held a similar role at Alexion Pharmaceuticals and amassed significant expertise during a 15-year tenure at Pfizer, where responsibilities included leading payer marketing strategies and cross-functional teams for rare diseases and inflammation therapies. Early career experiences at Wyeth involved managing finance, vaccines sales analysis, and chargeback processes. Jason Gidelson holds an MBA in Finance from the Fox School of Business at Temple University, a BS in Business Management from Bloomsburg University of Pennsylvania, and a Post MBA Certificate in Pharmaceutical Marketing from Saint Joseph's University.